Device Trial Radar · NCT04139564
EaseVRx for the Reduction of Chronic Pain and Opioid Use
Last checked: Nov 19, 2026Latest source record: Mar 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
Jan 11, 2021
Primary completion
Aug 31, 2022
Study completion Aug 31, 2022
Sponsor
- Lead sponsor
- AppliedVR Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Geisinger Clinic; National Institute on Drug Abuse (NIDA)
- First posted
- Oct 25, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
EaseVRx, a software-based virtual reality (VR) medical device, is intended to offer users a prescription pain management tool that manages the symptoms associated with chronic pain and reduces or eliminates the risk of opioid dependence. The investigators will conduct a proof-of-concept randomized study to assess the feasibility and efficacy of using EaseVRx as a 56-day, VR-based, at-home program among 100 chronic low back pain patients by gathering pilot data on the efficacy of the intervention in decreasing pain, reducing opioid/non-opioid pharmacotherapy, and improving pain-related quality of life.
Conditions
- Chronic Low-back Pain
Interventions
EaseVRx headsetDevice
EaseVRx is a virtual reality therapy intended to treat chronic pain
Active control VR sham programDevice
VR, 2d visual wildlife scenes similar to some EaseVRx content
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain: Numerical Pain Rating ScaleTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Geisinger Medical Center
Danville, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.